Family Office Of America (FOFA) Net Income towards Common Stockholders (2021 - 2026)
Family Office Of America (FOFA) posted Net Income towards Common Stockholders of $209049.0 for Q1 2026, up 185.94% sequentially from -$243255.0 in Q4 2025, and up 302.33% YoY from $51959.6 in Q1 2025.
Family Office Of America (FOFA) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends
Family Office Of America has reported Net Income towards Common Stockholders for 6 years, with the latest figure at $209049.0 in Q1 2026.
- Quarterly Net Income towards Common Stockholders rose 302.33% year-over-year to $209049.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$180378.0 (up 3.87% YoY) and the FY2025 annual result came in at -$492748.0, down 390.37% from the prior year.
- Net Income towards Common Stockholders climbed to $209049.0 in Q1 2026 per FOFA's latest filing, from -$243255.0 in the prior quarter.
- Over five years, Net Income towards Common Stockholders peaked at $943223.0 in Q4 2023 and troughed at -$1.6 million in Q2 2023.
- A 5-year average of -$124101.1 and a median of -$79811.0 in 2023 frame the typical range for Net Income towards Common Stockholders.
- The sharpest annual moves came in 2023 and 2025: Net Income towards Common Stockholders jumped 601.04% in 2023, then plunged 699.65% in 2025.
- Over 5 years, Net Income towards Common Stockholders stood at -$188254.0 in 2022, then surged by 601.04% to $943223.0 in 2023, then tumbled by 103.23% to -$30420.0 in 2024, then sank by 699.65% to -$243255.0 in 2025, then jumped by 185.94% to $209049.0 in 2026.
- According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $209049.0, -$243255.0, and -$50944.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Family Office Of America | 27.84 Mn | 27.20 Mn | 532,674.00 | -125,146.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 209,049.00 |
| Dec 31, 2025 | -243,255.00 |
| Sep 30, 2025 | -50,944.00 |
| Jun 30, 2025 | -95,228.00 |
| Mar 31, 2025 | -103,321.00 |
| Dec 31, 2024 | -30,420.00 |
| Sep 30, 2024 | -22,676.00 |
| Jun 30, 2024 | -31,228.00 |
| Mar 31, 2024 | -16,160.00 |
| Dec 31, 2023 | 943,223.00 |
| Sep 30, 2023 | -28,572.00 |
| Jun 30, 2023 | -1.64 Mn |
| Mar 31, 2023 | -79,811.00 |
| Dec 31, 2022 | -188,254.00 |
| Sep 30, 2022 | -126,659.00 |
| Jun 30, 2022 | -510,529.00 |
| Mar 31, 2022 | -95,073.00 |
| Dec 31, 2021 | -386,442.00 |
| Sep 30, 2021 | -518,866.00 |
| Jun 30, 2021 | -622,777.00 |